Crowd Reviews Partnered with Pulsus to Announce: Unleash the Enigma in Cancer Biology and Cells through CANCER BIOLOGY 2022
Crowd Reviews Partnered with Pulsus to Announce: Unleash the Enigma in Cancer Biology and Cells through CANCER BIOLOGY 2022
Pulsus Group hosts the 21st International Conference on Cancer Biology and Cell Science (Cancer Biology 2022) that discusses the new challenges and explores the prevention of Oncology.
- (1888PressRelease) March 26, 2022 - Cancer biology 2022 focuses on many interactive scientific sessions on different types of Disorders as well as various diagnostic and therapeutic advancements in this field. It also provides an opportunity to showcase your ingenuity to the Cancer Biology 2022 will be organized around the theme “New Challenges and explore the prevention of Oncology” on June 13-14, 2022 in Amsterdam, Netherlands.
The major focus of the Conference includes Advancements and breakthroughs in the fields of Cancer, the Latest uses of Cancer Therapies, Advances in the Cancer Research field: Emerging trends in Oncology, Advancements in Diagnostic & Therapeutic areas of Cancer, Future directions in Cancer, and many more.
The attendees of the Congress will enjoy special events and lectures featuring expertise in the field. It is a perfect platform for Oncologists, Surgeons, Oncology scholars, Psychologists, research scholars, University Professors, industrial professionals, and student delegates from Cancer Biology sectors to explore every single element in Cancer. Cancer Biology 2022 will also provide an excellent opportunity for budding scientists and young researchers through its special initiatives like the Young Researcher Forum, Poster Presentation, B2B, and Scientific Meetings.
All the papers to be presented in Cancer Biology 2022 will be published in the Journal of Carcinogenesis and Mutagenesis.
Conference Highlights:
• 100+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 30+ Plenary Speakers
• 5+ Exhibitors
• 18 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings
Statistics:
The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involve the use and administration of chemotherapy and oncology drugs to treat cancer.
An increase in cancer prevalence, surge in collaboration between pharmaceutical companies, and rise in cancer research are the key factors that augment the growth of the cancer therapeutics market. Furthermore, growth in the geriatric population is expected to boost the market growth.
However, high costs associated with oncology drug development along with adverse effects associated with cancer therapeutics are some of the factors that restrain the market growth. Conversely, the upsurge in demand for personalized medicine and the high potential of developing nations is expected to provide new opportunities for the market players in the future.
If you are interested to know more about Congress.
Contact: Rebecca Jason
Tel.: +44-3308187301
Email: cancerbiologycong ( @ ) gmail dot com
Website: https://cancerbiology.conferenceseries.com/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam